ArticleAmerican journal of cancer research2020

Targeting c-kit inhibits gefitinib resistant NSCLC cell growth and invasion through attenuations of stemness, EMT and acquired resistance.

Yueling Zhou et al.PubMed ↗Full text ↗

No numbers read from the abstract.